Trinity Biotech PLC (TRIB)
1.09
-0.06
(-5.22%)
USD |
NASDAQ |
Sep 27, 16:00
1.10
+0.01
(+0.92%)
After-Hours: 20:00
Trinity Biotech Accounts Receivable (Quarterly): 17.47M for June 30, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 17.47M |
March 31, 2024 | 17.32M |
December 31, 2023 | 10.70M |
September 30, 2023 | 15.10M |
June 30, 2023 | 13.87M |
March 31, 2023 | 13.59M |
December 31, 2022 | 12.62M |
September 30, 2022 | 17.26M |
June 30, 2022 | 15.91M |
March 31, 2022 | 16.90M |
December 31, 2021 | 13.29M |
September 30, 2021 | 16.82M |
June 30, 2021 | 15.36M |
March 31, 2021 | 14.86M |
December 31, 2020 | 20.02M |
September 30, 2020 | 21.66M |
June 30, 2020 | 17.05M |
March 31, 2020 | 19.98M |
December 31, 2019 | 17.75M |
September 30, 2019 | 24.81M |
June 30, 2019 | 24.33M |
March 31, 2019 | 23.57M |
December 31, 2018 | 21.32M |
September 30, 2018 | 23.38M |
June 30, 2018 | 23.14M |
Date | Value |
---|---|
March 31, 2018 | 22.12M |
December 31, 2017 | 17.24M |
September 30, 2017 | 24.60M |
June 30, 2017 | 24.86M |
March 31, 2017 | 22.68M |
December 31, 2016 | 18.34M |
September 30, 2016 | 25.80M |
June 30, 2016 | 27.83M |
March 31, 2016 | 26.26M |
December 31, 2015 | 19.50M |
September 30, 2015 | 27.15M |
June 30, 2015 | 28.34M |
March 31, 2015 | 27.64M |
December 31, 2014 | 20.28M |
September 30, 2014 | 25.19M |
June 30, 2014 | 27.16M |
March 31, 2014 | 24.13M |
December 31, 2013 | 19.76M |
September 30, 2013 | 23.12M |
June 30, 2013 | 17.43M |
March 31, 2013 | 15.30M |
December 31, 2012 | 12.62M |
September 30, 2012 | 15.57M |
June 30, 2012 | 14.92M |
March 31, 2012 | 25.68M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
10.70M
Minimum
Dec 2023
24.81M
Maximum
Sep 2019
16.62M
Average
16.86M
Median
Accounts Receivable (Quarterly) Benchmarks
Amarin Corp PLC | 123.69M |
DBV Technologies SA | -- |
Cellectis SA | 9.741M |
Adaptimmune Therapeutics PLC | 2.335M |
Akari Therapeutics PLC | -- |